---
title: "FDA Premarket Cybersecurity | MedTech Cyber Tips"
description: "Submit a cybersecurity package the FDA will accept. This guide provides actionable tips for medical device manufacturers to successfully navigate the FDA…"
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@graph": [
        {
          "@type": "WebSite",
          "@id": "https://medtechcybertips.com/#website",
          "url": "https://medtechcybertips.com/",
          "name": "MedTech Cyber Tips",
          "description": "The ultimate organized guide to medical device cybersecurity.",
          "inLanguage": "en-US",
          "publisher": {
            "@id": "https://medtechcybertips.com/#org"
          },
          "potentialAction": {
            "@type": "SearchAction",
            "target": "https://medtechcybertips.com/topics?q={search_term_string}",
            "query-input": "required name=search_term_string"
          }
        },
        {
          "@type": "Organization",
          "@id": "https://medtechcybertips.com/#org",
          "name": "MedTech Cyber Tips",
          "url": "https://medtechcybertips.com/",
          "logo": "https://medtechcybertips.com/icon-512.png",
          "sponsor": {
            "@type": "Organization",
            "name": "Blue Goat Cyber",
            "url": "https://bluegoatcyber.com",
            "sameAs": [
              "https://home.bluegoatcyber.com/",
              "https://codebluechart.com/",
              "https://why.bluegoatcyber.com/",
              "https://spdf.bluegoatcyber.com/",
              "https://threatmodel.bluegoatcyber.com/",
              "https://pentesting.bluegoatcyber.com/",
              "https://premarket.bluegoatcyber.com/",
              "https://fdaresponse.bluegoatcyber.com/",
              "https://postmarket.bluegoatcyber.com/",
              "https://goatwatch.bluegoatcyber.com/"
            ]
          }
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "headline": "FDA Premarket Cybersecurity",
      "description": "This guide provides actionable tips for medical device manufacturers to successfully navigate the FDA premarket cybersecurity submission process, ensuring clearance and avoiding common pitfalls such as rejections, deficiencies, and costly rework. It emphasizes comprehensive preparation and documentation.",
      "image": "https://medtechcybertips.com/og/topics/premarket.png",
      "datePublished": "2025-01-01",
      "dateModified": "2026-08-18",
      "author": {
        "@type": "Person",
        "@id": "https://medtechcybertips.com/authors/christian-espinosa",
        "name": "Christian Espinosa"
      },
      "reviewedBy": {
        "@type": "Person",
        "@id": "https://medtechcybertips.com/authors/editorial-team",
        "name": "MedTech Cyber Tips Editorial Team"
      },
      "publisher": {
        "@type": "Organization",
        "name": "MedTech Cyber Tips",
        "url": "https://medtechcybertips.com",
        "sponsor": {
          "@type": "Organization",
          "name": "Blue Goat Cyber"
        }
      },
      "mainEntityOfPage": "https://medtechcybertips.com/topics/premarket",
      "about": "Premarket, Submission"
    },
    {
      "@context": "https://schema.org",
      "@type": "Person",
      "@id": "https://medtechcybertips.com/authors/christian-espinosa",
      "url": "https://medtechcybertips.com/authors/christian-espinosa",
      "name": "Christian Espinosa",
      "jobTitle": "Founder & CEO, Blue Goat Cyber",
      "description": "Christian Espinosa is the founder and CEO of Blue Goat Cyber, a cybersecurity firm specializing in medical device penetration testing and FDA premarket cybersecurity submissions. He is a former U.S. Air Force officer, author, and speaker on secure product development for connected medical devices. His team has supported hundreds of 510(k) and De Novo cybersecurity packages aligned to Section 524B and the FDA's premarket cybersecurity guidance, and regularly performs threat modeling (STRIDE, attack trees), SBOM/VEX generation, and coordinated vulnerability disclosure engagements for MedTech manufacturers.",
      "knowsAbout": [
        "Medical device penetration testing",
        "FDA Section 524B",
        "FDA premarket cybersecurity guidance (Feb 3, 2026)",
        "STRIDE threat modeling for medical devices",
        "Secure Product Development Framework",
        "SBOM and VEX",
        "Coordinated vulnerability disclosure"
      ],
      "sameAs": [
        "https://bluegoatcyber.com/about",
        "https://www.linkedin.com/in/christianespinosa/"
      ],
      "worksFor": {
        "@type": "Organization",
        "name": "MedTech Cyber Tips",
        "url": "https://medtechcybertips.com/"
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "Person",
      "@id": "https://medtechcybertips.com/authors/editorial-team",
      "url": "https://medtechcybertips.com/authors/editorial-team",
      "name": "MedTech Cyber Tips Editorial Team",
      "jobTitle": "Medical Device Cybersecurity Editors",
      "description": "The MedTech Cyber Tips editorial team is a group of practitioners with hands-on experience across FDA premarket cybersecurity submissions, Secure Product Development Framework (SPDF) implementation, medical device threat modeling, and postmarket vulnerability management. Every article, checklist, and update on this site is reviewed for accuracy against the FDA's February 3, 2026 final premarket cybersecurity guidance, Section 524B of the FD&C Act, MDCG 2019-16 Rev.2, IEC 81001-5-1, ISO 14971, and the EU Cyber Resilience Act. The team also tracks 510(k) deficiency patterns and CVE trends affecting connected medical devices so guidance on the site stays current.",
      "knowsAbout": [
        "Medical device cybersecurity",
        "FDA Section 524B",
        "FDA premarket cybersecurity guidance (Feb 3, 2026)",
        "Secure Product Development Framework",
        "SBOM and VEX",
        "Medical device threat modeling",
        "Postmarket vulnerability management",
        "EU MDR cybersecurity (MDCG 2019-16 Rev.2)",
        "EU Cyber Resilience Act",
        "IEC 81001-5-1",
        "ISO 14971 risk management"
      ],
      "sameAs": [
        "https://bluegoatcyber.com/about"
      ],
      "worksFor": {
        "@type": "Organization",
        "name": "MedTech Cyber Tips",
        "url": "https://medtechcybertips.com/"
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://medtechcybertips.com"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Topics",
          "item": "https://medtechcybertips.com/topics"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Premarket",
          "item": "https://medtechcybertips.com/topics/premarket"
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What is a premarket cybersecurity submission?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "It is the cybersecurity portion of your 510(k), De Novo, or PMA package, addressing the six elements enumerated in Section 524B and detailed in the FDA's February 3 2026 premarket cybersecurity guidance: security risk management, security architecture, security testing, SBOM, vulnerability disclosure/handling, and labeling."
          }
        },
        {
          "@type": "Question",
          "name": "What are the most common reasons FDA rejects a cybersecurity submission?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Missing or shallow threat models, no penetration testing evidence, SBOMs without VEX, weak coordinated vulnerability disclosure processes, and cybersecurity claims that are not traceable back to design controls. Refuse-to-Accept decisions almost always cite one of these."
          }
        },
        {
          "@type": "Question",
          "name": "Do 510(k) submissions have the same cyber requirements as PMA?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes. Section 524B applies to any 'cyber device' regardless of submission pathway. The depth of documentation may scale with device risk class, but the six required elements are the same."
          }
        },
        {
          "@type": "Question",
          "name": "What is Section 524B in one paragraph?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Section 524B of the FD&C Act (added by the 2023 Omnibus) makes cybersecurity a statutory requirement for 'cyber devices.' Sponsors must submit a plan to monitor and address postmarket vulnerabilities, design and maintain the device to be reasonably cybersecure, and provide a Software Bill of Materials."
          }
        },
        {
          "@type": "Question",
          "name": "How long does the cyber section of a submission typically take to prepare?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "For a team with an SPDF in place, 4-8 weeks. For a team producing artifacts for the first time, 3-6 months. Threat modeling and independent penetration testing are usually the long-pole items."
          }
        }
      ]
    }
  ]
---

[Skip to main content](#main)

[

MedTech Cyber Tips

The Ultimate Guide



](/)

[Home](/)[Find Your Path](/journey)[All Topics](/topics)Reference[About](/about)

Search ⌘K

[All topics](/topics)

Premarket · Submission

# FDA Premarket Cybersecurity

This guide provides actionable tips for medical device manufacturers to successfully navigate the FDA premarket cybersecurity submission process, ensuring clearance and avoiding common pitfalls such as rejections, deficiencies, and costly rework. It emphasizes comprehensive preparation and documentation. 

For:  Medical device manufacturers and MedTech startups preparing for FDA premarket cybersecurity submissions.  5 min read Last updated Jul 10, 2026· 1mo ago  Print

By [Christian Espinosa](/authors/christian-espinosa) · Reviewed by MedTech Cyber Tips Editorial Team · Last reviewed July 2026 

Anatomy of an FDA cybersecurity submission

### Nine layers a reviewer expects to find

1.  1
    
    Cover letter & cybersecurity statement
    
    Frames the device, intended use, and cyber posture.
    
2.  2
    
    Security architecture views
    
    Global system, multi-patient harm, updateability, end-to-end.
    
3.  3
    
    SBOM + VEX
    
    Machine-readable, with vulnerability exploitability status.
    
4.  4
    
    Threat model
    
    STRIDE / attack trees / data flow mapped to risk file.
    
5.  5
    
    Cybersecurity risk assessment
    
    Per ISO 14971 + AAMI TIR57; controls and residual risk.
    
6.  6
    
    Testing evidence
    
    Pentest, fuzzing, vuln scan, SBOM analysis, requirements verification.
    
7.  7
    
    SPDF documentation
    
    Process objective evidence across the lifecycle.
    
8.  8
    
    Labeling for cybersecurity
    
    Operator guide, security configuration, anomaly response.
    
9.  9
    
    Postmarket management plan
    
    Monitoring, CVD, patching cadence, end-of-support.
    

8 structured tips

Checklist mode

## The walk-through

01

Documentation

### Comprehensive Documentation is Crucial

Copy link 

Prepare thorough and accurate documentation including [SPDF](/glossary/spdf), SBOMs, threat models, and penetration test reports to meet FDA expectations and avoid submission rejections. Incomplete documentation is a primary cause of FDA feedback and delays. 

02

Compliance

### Align with FDA and Industry Standards

Copy link 

Ensure your cybersecurity submission adheres to established standards and frameworks like [ISO 14971](/glossary/iso-14971), FDA 2026 Guidance, [UL 2900](/glossary/ul-2900), AAMI [TIR57](/glossary/tir57)/TIR97, NIST 800-115, [IEC 62304](/glossary/iec-62304), [IEC 81001-5-1](/glossary/iec-81001-5-1), and ANSI/AAMI [SW96](/glossary/sw96). This alignment demonstrates a robust cybersecurity posture. 

03

Technical

### Proactive Threat Modeling and Penetration Testing

Copy link 

Systematically identify threats using industry-standard methodologies and conduct deep vulnerability and penetration testing on both the device and its entire ecosystem (cloud/mobile). This proactive approach helps mitigate risks before submission. 

04

Technical

### Focus on the Full Ecosystem

Copy link 

When conducting penetration testing, consider not just the device but also its associated cloud infrastructure and mobile applications. Many vendors overlook the broader ecosystem, which can introduce vulnerabilities. 

05

Compliance

### Prepare for all Regulatory Pathways

Copy link 

Ensure your cybersecurity prepares you for 510(k), [PMA](/glossary/pma), and [De Novo](/glossary/de-novo) clearances by covering all necessary aspects of cybersecurity documentation and testing. This prevents rework and streamlines the submission process. 

06

Process

### Engage with Experts Early

Copy link 

Initiate discussions with cybersecurity experts early in your development process to understand FDA requirements and develop a tailored strategy. Early engagement can prevent delays and costly issues later on. 

07

Documentation

### Depth-of-Field Your SBOM

Copy link 

Include transitive dependencies, not just top-level components. Pin every component to a specific version with a hash and supplier. CycloneDX or SPDX, machine-readable — free-form component lists are being cited as incomplete under the Feb 3, 2026 guidance. 

08

Documentation

### Document End-of-Support Horizon

Copy link 

Labeling now must communicate a security-support horizon: how long you commit to shipping security updates and what happens after. Draft the [HDO](/glossary/hdo)\-facing statement early — a missing end-of-support plan is a common labeling deficiency. 

### Common pitfalls

-   Delayed submissions leading to significant revenue loss and increased investor pressure. 
-   Incomplete or incorrect documentation resulting in FDA rejections, deficiencies, and costly rework. 
-   Cybersecurity vulnerabilities causing product recalls, safety alerts, patient harm, and brand damage. 
-   Failure to test the full ecosystem (device + cloud/mobile) leading to overlooked vulnerabilities. 
-   Underestimating the complexity and evolving nature of FDA cybersecurity requirements. 

### Your next steps

1.  1 Conduct a discovery call with cybersecurity experts to assess your device, submission timeline, and risk profile. 
2.  2 Obtain a fixed-fee scope, deliverables list, and timeline for your cybersecurity submission to ensure no surprises or scope creep. 
3.  3 Begin developing or refining your Secure Product Development Framework (SPDF) and Software Bill of Materials (SBOMs). 
4.  4 Perform thorough threat modeling and penetration testing across the entire medical device ecosystem. 

### Sources & references

Authoritative guidance and standards underpinning this topic. Always confirm the latest revision with the publisher.

-   FDA [Cybersecurity in Medical Devices - Premarket Submissions (Feb 3 2026, final)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cybersecurity-medical-devices-quality-system-considerations-and-content-premarket-submissions)
-   FDA [eSTAR Program for 510(k) and De Novo Submissions](https://www.fda.gov/medical-devices/how-study-and-market-your-device/estar-program)
-   FDA [Refuse to Accept Policy for 510(k)s](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/refuse-accept-policy-510ks)
-   NTIA [NTIA Minimum Elements for an SBOM](https://www.ntia.gov/files/ntia/publications/sbom_minimum_elements_report.pdf)

## Frequently asked questions

Quick answers to the questions teams most often ask about this topic.

### What is a premarket cybersecurity submission? 

It is the cybersecurity portion of your 510(k), De Novo, or PMA package, addressing the six elements enumerated in Section 524B and detailed in the FDA's February 3 2026 premarket cybersecurity guidance: security risk management, security architecture, security testing, SBOM, vulnerability disclosure/handling, and labeling.

### What are the most common reasons FDA rejects a cybersecurity submission? 

Missing or shallow threat models, no penetration testing evidence, SBOMs without VEX, weak coordinated vulnerability disclosure processes, and cybersecurity claims that are not traceable back to design controls. Refuse-to-Accept decisions almost always cite one of these.

### Do 510(k) submissions have the same cyber requirements as PMA? 

Yes. Section 524B applies to any 'cyber device' regardless of submission pathway. The depth of documentation may scale with device risk class, but the six required elements are the same.

### What is Section 524B in one paragraph? 

Section 524B of the FD&C Act (added by the 2023 Omnibus) makes cybersecurity a statutory requirement for 'cyber devices.' Sponsors must submit a plan to monitor and address postmarket vulnerabilities, design and maintain the device to be reasonably cybersecure, and provide a Software Bill of Materials.

### How long does the cyber section of a submission typically take to prepare? 

For a team with an SPDF in place, 4-8 weeks. For a team producing artifacts for the first time, 3-6 months. Threat modeling and independent penetration testing are usually the long-pole items.

Sponsored | how Blue Goat Cyber℠ helps

### Submit a package the FDA will accept

Blue Goat Cyber℠ builds the cybersecurity sections of 510(k), De Novo, and PMA submissions, SBOM, threat model, testing, and the cybersecurity management plan.

[Get help with your premarket submission](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

4.9 / 5 · 15+ client reviews 

"Superb cyber-security auditing/testing. Blue Goat is knowledgeable, thorough, professional, and very cost-effective. Felt like we had an expert member of our team working with us to assure our software as a medical device was up-to-date on all aspects of cyber security. I give the Blue Goat team my highest possible recommendation."

Aram Salzman  · CEO, AngioWave Imaging

250+ FDA submissions · 0 rejections Veteran-owned, Scottsdale AZ Exclusively medical device cybersecurity 

On this page

5 min read

-   [01 · Comprehensive Documentation is Crucial](#tip-0)
-   [02 · Align with FDA and Industry Standards](#tip-1)
-   [03 · Proactive Threat Modeling and Penetration Testing](#tip-2)
-   [04 · Focus on the Full Ecosystem](#tip-3)
-   [05 · Prepare for all Regulatory Pathways](#tip-4)
-   [06 · Engage with Experts Early](#tip-5)
-   [07 · Depth-of-Field Your SBOM](#tip-6)
-   [08 · Document End-of-Support Horizon](#tip-7)
-   [Common pitfalls](#pitfalls)
-   [Your next steps](#next-steps)
-   [FAQ](#faq)

Deep dive

Hands-on help from Blue Goat Cyber

The team behind this guide ships the work - read the canonical service page.

[Visit on bluegoatcyber.com](https://bluegoatcyber.com/services/fda-premarket-cybersecurity-services)

Keep going

### Related topics

[

Overview

Start here. The big picture for MedTech security.

Read guide

](/topics/home)[

SPDF

Bake security into every stage of the device lifecycle.

Read guide

](/topics/spdf)[

Threat Modeling

Identify and reason about threats before they ship.

Read guide

](/topics/threatmodel)

Continue by phase

Jump to all guides for the lifecycle phase that fits where you are.

[Premarket](/journey/premarket) [Submission](/journey/submission)

[All topics](/topics)[

Next in Premarket

AI/ML Devices

Adversarial ML, model integrity, PCCPs, and the security surface unique to learning-enabled devices.



](/topics/aiml)

MedTech Cyber Tips

The organized, end-to-end guide to medical device cybersecurity, from concept through postmarket. Part of the Blue Goat Cyber family.

Topics

-   [Overview](/topics/home)
-   [Why It Matters](/topics/why)
-   [SPDF](/topics/spdf)
-   [Threat Modeling](/topics/threatmodel)
-   [Pentesting](/topics/pentesting)

Reference

-   [Glossary](/glossary)
-   [FDA vs MDR](/compare)
-   [Resources](/resources)
-   [Updates](/updates)
-   [RSS feed](/rss.xml)

© 2026 medtechcybertips.com. An educational resource sponsored by Blue Goat Cyber.

Not legal or regulatory advice.